Raúl Navaridas

421 total citations
17 papers, 180 citations indexed

About

Raúl Navaridas is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Raúl Navaridas has authored 17 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Raúl Navaridas's work include PI3K/AKT/mTOR signaling in cancer (6 papers), TGF-β signaling in diseases (4 papers) and Cancer-related Molecular Pathways (3 papers). Raúl Navaridas is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), TGF-β signaling in diseases (4 papers) and Cancer-related Molecular Pathways (3 papers). Raúl Navaridas collaborates with scholars based in Spain, United Kingdom and United States. Raúl Navaridas's co-authors include Xavier Matías‐Guiu, Xavier Dolcet, Núria Eritja, Mario Encinas, Marı́a Santacana, Andrée Yeramian, Sónia Gatius, Joaquim Egea, María Dosil Santamaría and Cristina Mirantes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Raúl Navaridas

16 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raúl Navaridas Spain 10 111 55 35 28 26 17 180
Divya Kriplani United Kingdom 5 96 0.9× 74 1.3× 31 0.9× 11 0.4× 36 1.4× 8 155
Alba Ferreirós Spain 7 71 0.6× 52 0.9× 49 1.4× 11 0.4× 14 0.5× 12 143
Ian Croy United Kingdom 6 66 0.6× 49 0.9× 35 1.0× 23 0.8× 26 1.0× 10 182
Ruotong Tian China 8 185 1.7× 54 1.0× 130 3.7× 43 1.5× 49 1.9× 14 274
Sara S. Oltra Spain 11 180 1.6× 104 1.9× 140 4.0× 33 1.2× 24 0.9× 19 298
Angelina I. Londoño United States 9 138 1.2× 124 2.3× 70 2.0× 77 2.8× 45 1.7× 17 288
Renlong Zou China 10 249 2.2× 73 1.3× 41 1.2× 18 0.6× 34 1.3× 20 313
Moitri Basu India 7 186 1.7× 42 0.8× 59 1.7× 16 0.6× 19 0.7× 8 226
Xiujie Sheng China 9 216 1.9× 35 0.6× 202 5.8× 18 0.6× 55 2.1× 18 319
Dorothy Hallberg United States 4 82 0.7× 43 0.8× 36 1.0× 16 0.6× 13 0.5× 6 132

Countries citing papers authored by Raúl Navaridas

Since Specialization
Citations

This map shows the geographic impact of Raúl Navaridas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl Navaridas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl Navaridas more than expected).

Fields of papers citing papers by Raúl Navaridas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl Navaridas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl Navaridas. The network helps show where Raúl Navaridas may publish in the future.

Co-authorship network of co-authors of Raúl Navaridas

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl Navaridas. A scholar is included among the top collaborators of Raúl Navaridas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl Navaridas. Raúl Navaridas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bonifaci, Núria, Raúl Navaridas, Joaquim Egea, et al.. (2025). Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503. Cell Death and Disease. 16(1). 705–705.
2.
Guzman, Asja, Tatsuya Kawase, Gizem Efe, et al.. (2025). Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway–dependent Rho/ROCK signaling. Proceedings of the National Academy of Sciences. 122(43). e2424904122–e2424904122. 1 indexed citations
3.
Dunbar, Karen J., et al.. (2024). Regulation of metastatic organotropism. Trends in cancer. 11(3). 216–231. 10 indexed citations
4.
Navaridas, Raúl, Andrée Yeramian, Joaquim Egea, et al.. (2023). In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers. Advanced Science. 10(32). e2303134–e2303134. 7 indexed citations
5.
Navaridas, Raúl, Andrée Yeramian, Joaquim Egea, et al.. (2023). Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling. Biomedicine & Pharmacotherapy. 168. 115817–115817. 13 indexed citations
6.
Barceló, Carla, Pol Sisó, Raúl Navaridas, et al.. (2022). M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors. British Journal of Cancer. 127(6). 1142–1152. 10 indexed citations
7.
Navaridas, Raúl, Andrée Yeramian, Núria Eritja, et al.. (2022). Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition. Scientific Reports. 12(1). 14821–14821. 4 indexed citations
8.
López‐Mejía, Isabel C., Jordi Pijuan, Raúl Navaridas, et al.. (2022). Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness. Molecular Oncology. 17(1). 98–118. 15 indexed citations
9.
Sisó, Pol, Natàlia Mota‐Martorell, Raúl Navaridas, et al.. (2022). ARID1A ‐deficient cells require HDAC6 for progression of endometrial carcinoma. Molecular Oncology. 16(11). 2235–2259. 13 indexed citations
10.
Cemeli, Tània, Raúl Navaridas, Xavier Dolcet, et al.. (2022). Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma. International Journal of Molecular Sciences. 23(15). 8199–8199. 4 indexed citations
11.
Eritja, Núria, Raúl Navaridas, Joaquim Egea, et al.. (2021). Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation. Cancers. 13(19). 4990–4990. 12 indexed citations
12.
Hernández, Luís, Raúl Navaridas, Natividad Blasco, et al.. (2021). ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status. Cancers. 13(15). 3803–3803. 5 indexed citations
13.
Blasco, Natividad, Raúl Navaridas, Andrea Irazoki, et al.. (2020). Involvement of the mitochondrial nuclease EndoG in the regulation of cell proliferation through the control of reactive oxygen species. Redox Biology. 37. 101736–101736. 11 indexed citations
14.
Barceló, Carla, Pol Sisó, Óscar Maiques, et al.. (2019). T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma. Journal of Investigative Dermatology. 140(6). 1253–1265. 19 indexed citations
15.
Santamaría, María Dosil, Raúl Navaridas, Cristina Mirantes, et al.. (2018). Tumor suppressive function of E2F‐1 on PTEN‐induced serrated colorectal carcinogenesis. The Journal of Pathology. 247(1). 72–85. 5 indexed citations
16.
Eritja, Núria, María Dosil Santamaría, Cristina Mirantes, et al.. (2017). A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. Cell Death and Differentiation. 24(8). 1443–1458. 23 indexed citations
17.
Santamaría, María Dosil, Cristina Mirantes, Núria Eritja, et al.. (2017). Palbociclib has antitumour effects on Pten‐deficient endometrial neoplasias. The Journal of Pathology. 242(2). 152–164. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026